{"id":116315,"date":"2026-04-25T04:25:45","date_gmt":"2026-04-25T04:25:45","guid":{"rendered":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/?p=116315"},"modified":"2026-04-25T04:25:46","modified_gmt":"2026-04-25T04:25:46","slug":"ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita","status":"publish","type":"post","link":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/","title":{"rendered":"IA e farmaci psichiatrici: rischio o svolta nella sanit\u00e0?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Una startup statunitense ottiene l\u2019autorizzazione a utilizzare un chatbot per rinnovare prescrizioni psichiatriche. Tra accesso alle cure e rischi clinici, cresce il dibattito tra esperti e regolatori.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Negli Stati Uniti, la startup Legion Health ha ottenuto il via libera nello Stato dello Utah per utilizzare un sistema di intelligenza artificiale nella gestione delle prescrizioni psichiatriche. Il chatbot potr\u00e0 rinnovare farmaci come Prozac e Zoloft, ma solo per pazienti gi\u00e0 stabilizzati e con prescrizioni inizialmente validate da uno psichiatra umano.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Secondo quanto riportato da The Verge, il sistema \u00e8 limitato a casi clinici considerati a basso rischio. Tuttavia, il tema solleva interrogativi rilevanti sul piano medico ed etico. Esperti della Harvard Medical School sottolineano che la gestione dei disturbi mentali richiede monitoraggio continuo, adattamento terapeutico e interpretazione di segnali non sempre espliciti.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tra le principali criticit\u00e0 evidenziate vi \u00e8 il rischio di \u201csovratrattamento\u201d, ovvero l\u2019automatizzazione eccessiva delle prescrizioni senza un\u2019adeguata valutazione clinica. Inoltre, i chatbot potrebbero non rilevare informazioni incomplete o fuorvianti fornite dai pazienti, compromettendo la qualit\u00e0 della cura.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Un precedente progetto pilota nello Utah, noto come Doctronic, aveva gi\u00e0 suscitato polemiche: test indipendenti hanno dimostrato che il sistema poteva generare raccomandazioni mediche pericolose, inclusi suggerimenti su sostanze inappropriate. Questo precedente rafforza le preoccupazioni sulla sicurezza dei modelli generativi in ambito sanitario.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Legion Health ha dichiarato che il sistema sar\u00e0 monitorato attraverso report mensili e revisioni da parte di medici e farmacisti. L\u2019obiettivo dichiarato \u00e8 migliorare l\u2019accesso alle cure, soprattutto nelle aree con carenza di specialisti.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Approfondimento e cronologia<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>2024-2025<\/strong> \u2013 Cresce l\u2019uso dell\u2019IA nella sanit\u00e0 (Organizzazione Mondiale della Sanit\u00e0: linee guida sull\u2019AI in medicina)<br><a href=\"https:\/\/www.who.int\/publications\">https:\/\/www.who.int\/publications<\/a><\/li>\n\n\n\n<li><strong>Dicembre 2025<\/strong> \u2013 Lancio del progetto Doctronic nello Utah (criticit\u00e0 rilevate da ricercatori indipendenti)<\/li>\n\n\n\n<li><strong>Aprile 2026<\/strong> \u2013 Autorizzazione a Legion Health per prescrizioni assistite da AI<\/li>\n\n\n\n<li><strong>2026 (previsto)<\/strong> \u2013 Possibile espansione nazionale del sistema negli USA<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Fonti:<\/strong> OMS, Harvard Medical School, The Verge<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Consigli di approfondimento<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>OMS \u2013 Etica e governance dell\u2019AI sanitaria<br>https:\/\/www.who.int\/health-topics\/artificial-intelligence<\/li>\n\n\n\n<li>Harvard Medical School \u2013 Digital Psychiatry<br><a href=\"https:\/\/hms.harvard.edu\">https:\/\/hms.harvard.edu<\/a><\/li>\n\n\n\n<li>FDA \u2013 Regolamentazione AI in ambito medico<br><a href=\"https:\/\/www.fda.gov\">https:\/\/www.fda.gov<\/a><\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Abstract: impatti e rischi<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">L\u2019introduzione dell\u2019IA nelle prescrizioni psichiatriche offre vantaggi in termini di accessibilit\u00e0 e riduzione dei tempi di attesa. Tuttavia, presenta rischi significativi: errori clinici, perdita di relazione medico-paziente e automazione non controllata. A livello sociale, potrebbe accentuare disuguaglianze sanitarie e generare sfiducia nei sistemi digitali. In prospettiva, sar\u00e0 cruciale definire standard rigorosi, garantire supervisione umana e rafforzare la trasparenza algoritmica.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-content\/uploads\/2026\/04\/ia-farmaci-psichiatrici-rischio-svolta-sanita-1024x683.webp\" alt=\"IA e farmaci psichiatrici: rischio o svolta nella sanit\u00e0?\" class=\"wp-image-116322\" srcset=\"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-content\/uploads\/2026\/04\/ia-farmaci-psichiatrici-rischio-svolta-sanita-1024x683.webp 1024w, https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-content\/uploads\/2026\/04\/ia-farmaci-psichiatrici-rischio-svolta-sanita-300x200.webp 300w, https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-content\/uploads\/2026\/04\/ia-farmaci-psichiatrici-rischio-svolta-sanita-768x512.webp 768w, https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-content\/uploads\/2026\/04\/ia-farmaci-psichiatrici-rischio-svolta-sanita-696x464.webp 696w, https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-content\/uploads\/2026\/04\/ia-farmaci-psichiatrici-rischio-svolta-sanita-1068x712.webp 1068w, https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-content\/uploads\/2026\/04\/ia-farmaci-psichiatrici-rischio-svolta-sanita.webp 1536w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Una startup statunitense ottiene l\u2019autorizzazione a utilizzare un chatbot per rinnovare prescrizioni psichiatriche. Tra accesso alle cure e rischi clinici, cresce il dibattito tra esperti e regolatori. Negli Stati Uniti, la startup Legion Health ha ottenuto il via libera nello Stato dello Utah per utilizzare un sistema di intelligenza artificiale nella gestione delle prescrizioni psichiatriche. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":116322,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"footnotes":""},"categories":[371],"tags":[263],"class_list":["post-116315","post","type-post","status-publish","format-standard","has-post-thumbnail","category-newshealthcare-aiopenmind","tag-salute"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IA e farmaci psichiatrici: rischio o svolta nella sanit\u00e0? &#8212; AIopenmind<\/title>\n<meta name=\"description\" content=\"IA e farmaci psichiatrici: rischi, benefici e regolazione delle prescrizioni AI negli USA\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IA e farmaci psichiatrici: rischio o svolta nella sanit\u00e0? &#8212; AIopenmind\" \/>\n<meta property=\"og:description\" content=\"IA e farmaci psichiatrici: rischi, benefici e regolazione delle prescrizioni AI negli USA\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/\" \/>\n<meta property=\"og:site_name\" content=\"AIopenmind\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/aiopenmind\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-25T04:25:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-25T04:25:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-content\/uploads\/2026\/04\/ia-farmaci-psichiatrici-rischio-svolta-sanita.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"adminanto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AIopenmind\" \/>\n<meta name=\"twitter:site\" content=\"@AIopenmind\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminanto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\\\/\"},\"author\":{\"name\":\"adminanto\",\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/#\\\/schema\\\/person\\\/497572e8ff03fd87ebefe4f290570051\"},\"headline\":\"IA e farmaci psichiatrici: rischio o svolta nella sanit\u00e0?\",\"datePublished\":\"2026-04-25T04:25:45+00:00\",\"dateModified\":\"2026-04-25T04:25:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\\\/\"},\"wordCount\":419,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/ia-farmaci-psichiatrici-rischio-svolta-sanita.webp\",\"keywords\":[\"Salute\"],\"articleSection\":[\"SALUTE\"],\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\\\/\",\"url\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\\\/\",\"name\":\"IA e farmaci psichiatrici: rischio o svolta nella sanit\u00e0? &#8212; AIopenmind\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/ia-farmaci-psichiatrici-rischio-svolta-sanita.webp\",\"datePublished\":\"2026-04-25T04:25:45+00:00\",\"dateModified\":\"2026-04-25T04:25:46+00:00\",\"description\":\"IA e farmaci psichiatrici: rischi, benefici e regolazione delle prescrizioni AI negli USA\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/ia-farmaci-psichiatrici-rischio-svolta-sanita.webp\",\"contentUrl\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/ia-farmaci-psichiatrici-rischio-svolta-sanita.webp\",\"width\":1536,\"height\":1024,\"caption\":\"IA e farmaci psichiatrici: rischio o svolta nella sanit\u00e0?\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IA e farmaci psichiatrici: rischio o svolta nella sanit\u00e0?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/#website\",\"url\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/\",\"name\":\"AIopenmind\",\"description\":\"Artificial Intelligence\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/#organization\",\"name\":\"AIopenmind\",\"url\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/aiopenmind.jpg\",\"contentUrl\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/aiopenmind.jpg\",\"width\":332,\"height\":217,\"caption\":\"AIopenmind\"},\"image\":{\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/aiopenmind\",\"https:\\\/\\\/x.com\\\/AIopenmind\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/aiopenmind\\\/\",\"https:\\\/\\\/www.tiktok.com\\\/@aiopenmind\",\"https:\\\/\\\/www.instagram.com\\\/aiopenmind\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC_0dHy6JRrolCShIZS6D0Hw\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/#\\\/schema\\\/person\\\/497572e8ff03fd87ebefe4f290570051\",\"name\":\"adminanto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2139dfab7b92d46fd4478972312bf205fb9ddf4011d3d4d2d10d81c6221daba6?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2139dfab7b92d46fd4478972312bf205fb9ddf4011d3d4d2d10d81c6221daba6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2139dfab7b92d46fd4478972312bf205fb9ddf4011d3d4d2d10d81c6221daba6?s=96&d=mm&r=g\",\"caption\":\"adminanto\"},\"sameAs\":[\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\"],\"url\":\"https:\\\/\\\/www.aiopenmind.it\\\/ArtificialIntelligence\\\/author\\\/adminanto\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IA e farmaci psichiatrici: rischio o svolta nella sanit\u00e0? &#8212; AIopenmind","description":"IA e farmaci psichiatrici: rischi, benefici e regolazione delle prescrizioni AI negli USA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/","og_locale":"it_IT","og_type":"article","og_title":"IA e farmaci psichiatrici: rischio o svolta nella sanit\u00e0? &#8212; AIopenmind","og_description":"IA e farmaci psichiatrici: rischi, benefici e regolazione delle prescrizioni AI negli USA","og_url":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/","og_site_name":"AIopenmind","article_publisher":"https:\/\/www.facebook.com\/aiopenmind","article_published_time":"2026-04-25T04:25:45+00:00","article_modified_time":"2026-04-25T04:25:46+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-content\/uploads\/2026\/04\/ia-farmaci-psichiatrici-rischio-svolta-sanita.webp","type":"image\/webp"}],"author":"adminanto","twitter_card":"summary_large_image","twitter_creator":"@AIopenmind","twitter_site":"@AIopenmind","twitter_misc":{"Scritto da":"adminanto","Tempo di lettura stimato":"3 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/#article","isPartOf":{"@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/"},"author":{"name":"adminanto","@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/#\/schema\/person\/497572e8ff03fd87ebefe4f290570051"},"headline":"IA e farmaci psichiatrici: rischio o svolta nella sanit\u00e0?","datePublished":"2026-04-25T04:25:45+00:00","dateModified":"2026-04-25T04:25:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/"},"wordCount":419,"commentCount":0,"publisher":{"@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/#organization"},"image":{"@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/#primaryimage"},"thumbnailUrl":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-content\/uploads\/2026\/04\/ia-farmaci-psichiatrici-rischio-svolta-sanita.webp","keywords":["Salute"],"articleSection":["SALUTE"],"inLanguage":"it-IT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/","url":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/","name":"IA e farmaci psichiatrici: rischio o svolta nella sanit\u00e0? &#8212; AIopenmind","isPartOf":{"@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/#primaryimage"},"image":{"@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/#primaryimage"},"thumbnailUrl":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-content\/uploads\/2026\/04\/ia-farmaci-psichiatrici-rischio-svolta-sanita.webp","datePublished":"2026-04-25T04:25:45+00:00","dateModified":"2026-04-25T04:25:46+00:00","description":"IA e farmaci psichiatrici: rischi, benefici e regolazione delle prescrizioni AI negli USA","breadcrumb":{"@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/#primaryimage","url":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-content\/uploads\/2026\/04\/ia-farmaci-psichiatrici-rischio-svolta-sanita.webp","contentUrl":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-content\/uploads\/2026\/04\/ia-farmaci-psichiatrici-rischio-svolta-sanita.webp","width":1536,"height":1024,"caption":"IA e farmaci psichiatrici: rischio o svolta nella sanit\u00e0?"},{"@type":"BreadcrumbList","@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/ia-e-farmaci-psichiatrici-rischio-o-svolta-nella-sanita\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/"},{"@type":"ListItem","position":2,"name":"IA e farmaci psichiatrici: rischio o svolta nella sanit\u00e0?"}]},{"@type":"WebSite","@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/#website","url":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/","name":"AIopenmind","description":"Artificial Intelligence","publisher":{"@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/#organization","name":"AIopenmind","url":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/#\/schema\/logo\/image\/","url":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-content\/uploads\/2021\/04\/aiopenmind.jpg","contentUrl":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-content\/uploads\/2021\/04\/aiopenmind.jpg","width":332,"height":217,"caption":"AIopenmind"},"image":{"@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/aiopenmind","https:\/\/x.com\/AIopenmind","https:\/\/www.linkedin.com\/in\/aiopenmind\/","https:\/\/www.tiktok.com\/@aiopenmind","https:\/\/www.instagram.com\/aiopenmind\/","https:\/\/www.youtube.com\/channel\/UC_0dHy6JRrolCShIZS6D0Hw"]},{"@type":"Person","@id":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/#\/schema\/person\/497572e8ff03fd87ebefe4f290570051","name":"adminanto","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/2139dfab7b92d46fd4478972312bf205fb9ddf4011d3d4d2d10d81c6221daba6?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2139dfab7b92d46fd4478972312bf205fb9ddf4011d3d4d2d10d81c6221daba6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2139dfab7b92d46fd4478972312bf205fb9ddf4011d3d4d2d10d81c6221daba6?s=96&d=mm&r=g","caption":"adminanto"},"sameAs":["https:\/\/www.aiopenmind.it\/ArtificialIntelligence"],"url":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/author\/adminanto\/"}]}},"_links":{"self":[{"href":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-json\/wp\/v2\/posts\/116315","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-json\/wp\/v2\/comments?post=116315"}],"version-history":[{"count":1,"href":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-json\/wp\/v2\/posts\/116315\/revisions"}],"predecessor-version":[{"id":116323,"href":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-json\/wp\/v2\/posts\/116315\/revisions\/116323"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-json\/wp\/v2\/media\/116322"}],"wp:attachment":[{"href":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-json\/wp\/v2\/media?parent=116315"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-json\/wp\/v2\/categories?post=116315"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aiopenmind.it\/ArtificialIntelligence\/wp-json\/wp\/v2\/tags?post=116315"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}